在临床试验中分析时间的动态预测,使用纵向和时间到事件数据的联合模型
Ryunosuke Machida1,2, Kentaro Sakamaki3,4, Tomohiro Ohigashi5
1Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan.
Statistics in medicine
|December 15, 2025
概括
预测临床试验分析时间对于资源管理至关重要. 使用纵向数据的新方法,如前列腺特异性抗原 (PSA) 水平,与仅使用基线数据的方法相比,提高了预测准确性.
科学领域:
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
- 纵向数据分析 纵向数据分析
背景情况:
- 事件驱动的临床试验依赖于对资源管理的及时分析.
- 当前的预测方法往往忽略了有价值的纵向共变量数据.
- 准确的分析时间对于优化试验成本和操作至关重要.
研究的目的:
- 开发和评估一种用于预测临床试验分析时间的新方法.
- 将纵向测量的共变量纳入动态预测模型.
- 用不同的共变量数据,将拟议的方法与现有方法进行比较.
主要方法:
- 开发了一个动态预测方法,使用联合模型来预测时间到事件的结果和纵向共变量.
- 与没有共变量和仅使用基线共变量的方法进行预测准确性的比较.
- 利用模拟数据,根据预测准确度评估性能.
主要成果:
- 采用纵向共变量的拟议方法显著提高了分析时间的预测准确性.
- 仅依赖基线或没有共变量的方法显示出较低的预测准确度.
- 数字实验证实了联合建模方法的增强性能.
结论:
- 整合纵向共变量数据的联合模型在预测临床试验分析时间方面提供了更高的准确性.
- 这种方法对于具有时间到事件终点和可用的纵向测量结果的试验尤其有价值.
- 开发的方法为优化临床试验规划和资源配置提供了一个强大的工具.
相关概念视频
Introduction To Survival Analysis
712
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
712
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
293
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
293
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
461
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
461
Comparing the Survival Analysis of Two or More Groups
533
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
533
Noncompartmental Analysis: Mean Residence Time
544
According to statistical moment theory, mean residence time (MRT) is an important measure in pharmacokinetics. MRT can be defined as the expected mean of a probability density function distribution. It provides valuable insights into drug disposition in the body.
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
544
Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K


